Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Leukemia × Bortezomib × Clear all

Phase

Status

Completed 14 Terminated 3 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 29 Neoplasms, Plasma Cell 11 Recurrence 6 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myeloid, Acute 2 Immunoglobulin Light-chain Amyloidosis 2 Glioblastoma 2 Waldenstrom Macroglobulinemia 1 Renal Insufficiency 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Pathologic Complete Response 1 Paraproteinemias 1 Pancreatic Neoplasms 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm, Residual 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma 1 Liver Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Plasma Cell 1 Leukemia 1 Hypoxia 1 Hematologic Diseases 1 Gallbladder Neoplasms 1 Colonic Neoplasms 1

Interventions

Cytarabine 35 Cyclophosphamide 25 Radiotherapy 17 Etoposide 17 Daunorubicin 16 Busulfan 15 Methotrexate 14 Idarubicin 14 Peripheral Blood Stem Cell Transplantation 13 Mercaptopurine 12 Dexamethasone 12 Vincristine 11 Thioguanine 9 pegaspargase 8 Mitoxantrone 8 Doxorubicin 8 Antilymphocyte Serum 8 fludarabine phosphate 7 Polymerase Chain Reaction 7 Filgrastim 7 Cyclosporine 7 Asparaginase 7 Prednisone 6 Prednisolone 6 Mycophenolic Acid 5 Melphalan 5 Gene Expression Profiling 5 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 4 Leucovorin 4 Imatinib Mesylate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510939 2009-08-14

HEMOS AML 0106

University of Bologna

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡